Table 4 Category of evidence, strength of recommendations and level of agreement of recommendations
| Recommendation no. | Category of evidence | Strength of recommendation | Level of agreement (VAS, mm) | |
| Whole committee | Experts in the field | |||
| 1 Eye involvement | Ib | A/D | 9.57 (0.51) | 9.73 (0.47) |
| 2 Refractory eye involvement | Ib/IIb | C/D | 8.71 (0.91) | 8.9 (0.83) |
| 3 Major vessel disease | III | C | 8.64 (1.01) | 8.88 (0.83) |
| 4 Anticoagulation | IV | D | 8.50 (1.74) | 8.86 (1.46) |
| 5 Gastrointestinal involvement | III | C | 8.71 (0.47) | 8.75 (0.46) |
| 6 Joint involvement | Ib | A | 9.0 (0.78) | 8.89 (0.78) |
| 7 Neurological involvement | III | C/D | 8.50 (0.65) | 8.44 (0.73) |
| 8 Ciclosporine A neurotoxicity | III | C | 8.79 (0.70) | 8.78 (0.68) |
| 9 Mucocutaneous involvement | Ib | A/C | 9.07 (0.47) | 9.11 (0.11) |
-
Values are given as mean (SD) where appropriate.
